HPLC-fluorescence assay for measuring mosapride in small volumes of rat plasma.
暂无分享,去创建一个
[1] Fa-mei Li,et al. Characterization of metabolic profile of mosapride citrate in rat and identification of two new metabolites: Mosapride N-oxide and morpholine ring-opened mosapride by UPLC-ESI-MS/MS. , 2009, Journal of pharmaceutical and biomedical analysis.
[2] A. Kotani,et al. Liquid chromatography-tandem mass spectrometric method for determination of mosapride citrate in equine tissues. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[3] Feng Qin,et al. [Determination of mosapride in human plasma by high performance liquid chromatography tandem mass spectrometry]. , 2007, Yao xue xue bao = Acta pharmaceutica Sinica.
[4] C. Chou,et al. Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile. , 2007, Journal of chromatography. A.
[5] Y. Nakajima,et al. Enhancement of the intrinsic defecation reflex by mosapride, a 5-HT4 agonist, in chronically lumbosacral denervated guinea pigs. , 2006, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.
[6] R. Nageswara Rao,et al. Enantioselective determination of a gastroprokinetic drug using amylose tris-(3,5-dimethylphenylcarbamate) as a stationary phase by HPLC. , 2006, Journal of pharmaceutical and biomedical analysis.
[7] N. V. Ramakrishna,et al. Validation and application of a high-performance liquid chromatography--tandem mass spectrometry assay for mosapride in human plasma. , 2005, Biomedical chromatography : BMC.
[8] C. Chou,et al. Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] O. Y. Hu,et al. Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[10] S. Alvi,et al. Development and validation of a liquid chromatographic method for determination of related-substances of mosapride citrate in bulk drugs and pharmaceuticals. , 2004, Journal of pharmaceutical and biomedical analysis.
[11] C. Chou,et al. Rapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] H. Saitoh,et al. Drug interaction between mosapride and erythromycin without electrocardiographic changes. , 2003, Japanese heart journal.
[13] T. K. Murthy,et al. A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations. , 2002, Die Pharmazie.
[14] T. K. Murthy,et al. The Determination of Mosapride Citrate in Bulk Drug Samples and Pharmaceutical Dosage Forms Using HPLC , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[15] C. Chou,et al. Determination of delavirdine in very small volumes of plasma by high-performance liquid chromatography with fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[16] T. Mushiroda,et al. The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[17] Y. Mizuki,et al. Simultaneous enantiomeric determination of a gastroprokinetic agent mosapride citrate and its metabolite in plasma using alpha 1-acid glycoprotein HPLC column. , 1997, Journal of pharmaceutical and biomedical analysis.
[18] Y. Mizuki,et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats. , 1993, Arzneimittel-Forschung.
[19] H Miyazaki,et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. , 1993, Arzneimittel-Forschung.
[20] M. Patel,et al. High-performance liquid chromatography and thin-layer chromatography for the simultaneous quantitation of rabeprazole and mosapride in pharmaceutical products. , 2008, Journal of chromatographic science.
[21] D. M. Robinson,et al. Mosapride in gastrointestinal disorders. , 2008, Drugs.
[22] A. Asakawa,et al. Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying. , 2006, Journal of diabetes and its complications.